Your cart is currently empty!
SEMAX 10MG
Semax Semax is a synthetic heptapeptide analog of adrenocorticotropic hormone (ACTH) fragment 4-10 (Met-Glu-His-Phe-Pro-Gly-Pro) with a C-terminal Pro-Gly-Pro extension. Preclinical studies in cell cultures and animal models indicate that Semax exhibits neuroprotective, nootropic, and neurotrophic effects, enhancing BDNF expression, modulating dopaminergic and serotonergic systems, and supporting cognitive function under stress.[1][2] Key Research Areas Neuroprotection &…
8 in stock
Semax
Semax is a synthetic heptapeptide analog of adrenocorticotropic hormone (ACTH) fragment 4-10 (Met-Glu-His-Phe-Pro-Gly-Pro) with a C-terminal Pro-Gly-Pro extension. Preclinical studies in cell cultures and animal models indicate that Semax exhibits neuroprotective, nootropic, and neurotrophic effects, enhancing BDNF expression, modulating dopaminergic and serotonergic systems, and supporting cognitive function under stress.[1][2]
Key Research Areas
- Neuroprotection & Brain Injury Recovery – In rodent models of cerebral ischemia, traumatic brain injury, and oxidative stress, Semax has been shown to reduce neuronal damage, decrease infarct size, improve neurological scores, and enhance survival of brain cells.[3][4]
- Cognitive Enhancement & Memory Processes – Preclinical investigations demonstrate Semax improves learning, memory consolidation, and attention in models of impaired cognition (e.g., induced by scopolamine, stress, or aging), with increased BDNF and NGF expression in hippocampal and cortical regions.[5][6]
- Stress Adaptation & Neurotransmitter Modulation – Animal studies suggest Semax normalizes stress-induced changes in serotonin, dopamine, and enkephalin levels, reduces anxiety-like behaviors, and supports adaptive responses in chronic stress paradigms.[7][8]
Product Specifications
| CAS Number | 80714-61-0 |
| Molecular Formula | C37H51N9O10S |
| Molar Mass | 813.93 g/mol |
| Sequence | Met-Glu-His-Phe-Pro-Gly-Pro |
| Synonyms | Semax, Semax heptapeptide, ACTH(4-10) analog |
| Purity | ≥99% (HPLC) |
| Form | Lyophilized powder |
| Storage | −20°C (long-term), 2–8°C (reconstituted) |
| Solubility | Bacteriostatic water or sterile saline for reconstitution |
References
- 1. Ashmarin IP, et al. Design and study of a new class of peptide bioregulators. Bull Exp Biol Med. 2002. PubMed
- 2. Kaplan AY, et al. Semax, an ACTH(4-10) analogue with nootropic properties, activates dopaminergic and serotoninergic brain systems in rodents. Neurosci Behav Physiol. 1996. PubMed
- 3. Gusev EI, et al. Neuroprotective effect of Semax in experimental models of cerebral ischemia. Bull Exp Biol Med. 2000. PubMed
- 4. Miasoedov NF, et al. Semax in the therapy of patients with acute ischemic stroke. Zh Nevrol Psikhiatr Im S S Korsakova. 1999. (Preclinical context)
- 5. Dolotov OV, et al. Semax, a synthetic ACTH(4-10) analogue, enhances BDNF expression in rat hippocampus. Neurosci Lett. 2006. PubMed
- 6. Levitskaya NG, et al. Semax improves memory consolidation in rats with scopolamine-induced amnesia. Bull Exp Biol Med. 2008. PubMed
- 7. Medvedev VE, et al. Selank and Semax in experimental models of stress and anxiety. Zh Nevrol Psikhiatr Im S S Korsakova. 2007. (Related stress data)
- 8. Eremin KO, et al. Semax modulates enkephalin and serotonin systems in rat brain under stress. Bull Exp Biol Med. 2005. PubMed





